Genuit Group Valuation

Is GEN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of GEN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: GEN (£4.19) is trading above our estimate of fair value (£3.22)

Significantly Below Fair Value: GEN is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for GEN?

Key metric: As GEN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for GEN. This is calculated by dividing GEN's market cap by their current earnings.
What is GEN's PE Ratio?
PE Ratio44.1x
EarningsUK£23.60m
Market CapUK£1.04b

Price to Earnings Ratio vs Peers

How does GEN's PE Ratio compare to its peers?

The above table shows the PE ratio for GEN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average17.3x
FAN Volution Group
26x12.1%UK£1.1b
JHD James Halstead
19.5x4.1%UK£825.2m
NXR Norcros
8.9x-1.2%UK£239.7m
ECEL Eurocell
14.8x22.3%UK£185.1m
GEN Genuit Group
44.1x32.6%UK£1.0b

Price-To-Earnings vs Peers: GEN is expensive based on its Price-To-Earnings Ratio (44.1x) compared to the peer average (17.3x).


Price to Earnings Ratio vs Industry

How does GEN's PE Ratio compare vs other companies in the European Building Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
GEN 44.1xIndustry Avg. 20.0xNo. of Companies13PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: GEN is expensive based on its Price-To-Earnings Ratio (44.1x) compared to the European Building industry average (19.9x).


Price to Earnings Ratio vs Fair Ratio

What is GEN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GEN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio44.1x
Fair PE Ratio27x

Price-To-Earnings vs Fair Ratio: GEN is expensive based on its Price-To-Earnings Ratio (44.1x) compared to the estimated Fair Price-To-Earnings Ratio (27x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst GEN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUK£4.19
UK£5.05
+20.6%
7.9%UK£5.46UK£4.20n/a9
Nov ’25UK£4.70
UK£5.05
+7.5%
7.9%UK£5.46UK£4.20n/a9
Oct ’25UK£4.69
UK£5.02
+6.9%
8.1%UK£5.46UK£4.20n/a8
Sep ’25UK£4.60
UK£5.02
+9.0%
8.1%UK£5.46UK£4.20n/a8
Aug ’25UK£5.07
UK£4.95
-2.5%
9.7%UK£5.45UK£3.85n/a8
Jul ’25UK£4.35
UK£4.80
+10.3%
10.5%UK£5.45UK£3.85n/a9
Jun ’25UK£4.51
UK£4.63
+2.8%
11.6%UK£5.45UK£3.85n/a8
May ’25UK£4.38
UK£4.48
+2.3%
9.3%UK£5.00UK£3.85n/a8
Apr ’25UK£4.41
UK£4.48
+1.6%
9.3%UK£5.00UK£3.85n/a8
Mar ’25UK£4.04
UK£4.42
+9.3%
8.4%UK£5.00UK£3.90n/a8
Feb ’25UK£4.28
UK£4.29
+0.2%
7.3%UK£4.80UK£3.90n/a8
Jan ’25UK£4.04
UK£3.94
-2.4%
9.2%UK£4.60UK£3.26n/a8
Dec ’24UK£3.34
UK£3.74
+12.0%
12.3%UK£4.60UK£3.20n/a7
Nov ’24UK£2.69
UK£3.75
+39.5%
12.5%UK£4.60UK£3.20UK£4.707
Oct ’24UK£3.30
UK£3.76
+14.0%
11.7%UK£4.60UK£3.20UK£4.698
Sep ’24UK£3.23
UK£3.79
+17.2%
10.8%UK£4.60UK£3.20UK£4.608
Aug ’24UK£3.13
UK£3.78
+21.0%
12.1%UK£4.60UK£3.20UK£5.077
Jul ’24UK£2.94
UK£3.78
+28.8%
12.1%UK£4.60UK£3.20UK£4.357
Jun ’24UK£3.21
UK£3.66
+14.2%
8.5%UK£4.08UK£3.20UK£4.517
May ’24UK£3.01
UK£3.57
+18.8%
7.2%UK£3.86UK£3.20UK£4.387
Apr ’24UK£2.79
UK£3.57
+28.0%
7.2%UK£3.86UK£3.20UK£4.417
Mar ’24UK£3.04
UK£3.72
+22.6%
9.4%UK£4.47UK£3.30UK£4.047
Feb ’24UK£3.28
UK£3.62
+10.4%
11.0%UK£4.47UK£3.13UK£4.287
Jan ’24UK£2.81
UK£3.64
+29.6%
11.8%UK£4.47UK£3.13UK£4.046
Dec ’23UK£3.25
UK£3.64
+12.1%
11.8%UK£4.47UK£3.13UK£3.346
Nov ’23UK£2.58
UK£3.88
+50.2%
14.0%UK£4.70UK£3.13UK£2.696

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies